Skip to main content

Table 16 Incremental cost-effectiveness results—univariate analysis

From: The multimorbidity collaborative medication review and decision making (MyComrade) study: a pilot cluster randomised trial in two healthcare systems

Variable/analysis

Incremental analysis (intervention minus control)

Intervention

Control

Cost analysis

 Mean total cost (SD)

2572.60 (5463.10)

1361.67 (2285.11)

 Difference in mean total cost € (95% CIs), [p-value]

1211, (− 278, 2699), [0.110]

Health outcome analysis

 Mean QALYS (SD)

0.45 (0.20)

0.39 (0.22)

 Difference in mean QALYs, (95% CIs), [p-value]

0.057, (− 0.036, 0.150), [0.224]

  1. CI Confidence intervals